SCHEMBL1176173

SCHEMBL1176173

CCCCCCCCc1cc2ccccc2c(C(=O)O)c1CCCCCCCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 6/20 0.51
MCL1 Q07820 6/20 0.51
BCL2L1 Q07817 5/20 0.51
BAK1 Q16611 5/20 0.51
KAT8 Q9H7Z6 3/20 0.51
PPARA Q07869 3/20 0.51
PPARG P37231 2/20 0.51
SAE1 Q9UBE0 2/20 0.51
EP300 Q09472 2/20 0.51
KAT5 Q92993 2/20 0.51
KAT2A Q92830 1/20 0.51
KAT2B Q92831 1/20 0.51
KDM4E B2RXH2 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
GLA P06280 1/20 0.49
HPGD P15428 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL163402 1.00 BID (0.51) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL27266684 1.00 BID (0.51) BIDMCL1BCL2L1BAK1KAT8
Ammonia Solution, Strong SCHEMBL7713469 0.99 BID (0.50) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL27715457 0.99 BID (0.50) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL28277939 0.99 BID (0.50) BIDMCL1BCL2L1BAK1KAT8
Ammonia Solution, Strong SCHEMBL7713467 0.99 BID (0.50) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL7594370 0.99 KDM4E (0.50) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL7745863 0.94 KDM4E (0.51) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL5575880 0.89 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL7184877 0.89 BID (0.54) BIDMCL1BCL2L1BAK1KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799317-B2 Photostabilizers, UV absorbers, and methods of photostabilizing compositions HALLSTAR INNOVATIONS CORP. (US) 2010-09-21 US claimed
US-20060257338-A1 Novel photostabilizers, UV absorbers, and methods, of photostabilizing compositions CPH INNOVATIONS CORP. (US) 2006-11-16 US claimed
US-8426054-B2 Laminated porous film and separator for cell MITSUBISHI PLASTICS, INC. (JP) 2013-04-23 US disclosed
US-7981402-B2 Alkyl benzene sulfonyl urea photostabilizers and UV-absorbers HALLSTAR INNOVATIONS CORP. (US) 2011-07-19 US disclosed
US-20110033396-A1 NOVEL PHOTOSTABILIZERS, UV ABSORBERS, AND METHODS OF PHOTOSTABILIZING COMPOSITIONS HALLSTAR ONNOVATIONS CORP. (US) 2011-02-10 US disclosed
US-7799317-B2 Photostabilizers, UV absorbers, and methods of photostabilizing compositions HALLSTAR INNOVATIONS CORP. (US) 2010-09-21 US disclosed
US-20100151311-A1 LAMINATED POROUS FILM AND SEPARATOR FOR CELL MITSUBISHI PLASTICS, INC. (JP) 2010-06-17 US disclosed
EP-2145757-A1 LAMINATED POROUS FILM AND SEPARATOR FOR CELL Mitsubishi Plastics, Inc. (JP) 2010-01-20 EP disclosed
US-20060257338-A1 Novel photostabilizers, UV absorbers, and methods, of photostabilizing compositions CPH INNOVATIONS CORP. (US) 2006-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110033396-A1 NOVEL PHOTOSTABILIZERS, UV ABSORBERS, AND METHODS OF PHOTOSTABILIZING COMPOSITIONS ERCC1, ERCC4, TTPA BID 4404/4885MCL1 1642/4885BCL2L1 2630/4885
US-20060257338-A1 Novel photostabilizers, UV absorbers, and methods, of photostabilizing compositions TTPA, ERCC1, ERCC4 BID 4501/4885MCL1 2020/4885BCL2L1 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.